Abbott Laboratories (NYSE:ABT) is one of the top 10 defensive stocks to consider in a volatile market. On July 3, analysts at ...

Abbott Laboratories’ Debt totaled $15 Bil at the end of the latest quarter, while its market capitalization stands at $233 ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move ...

Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before.

The sensor patch market was valued at $1.6 billion in 2022, and is estimated to reach $56.4 billion by 2032, growing at a CAGR of 43.2% from 2023 to 2032. Proactive surge in manufacturing output, ...

This was the stock's second consecutive day of losses.

Abbott Laboratories's ABT short percent of float has risen 3.45% since its last report. The company recently reported that it ...

Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc.

In the first quarter of 2025, the company delivered strong earnings and outperformed a group of medical device peers, despite ...